BioRestorative Therapies (BRTX) Short-term Investments (2022 - 2025)

BioRestorative Therapies (BRTX) has 4 years of Short-term Investments data on file, last reported at $1.4 million in Q4 2025.

• Quarterly Short-term Investments fell 85.84% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 85.84% YoY) and the FY2025 annual result came in at $1.4 million, down 85.84% from the prior year.
• Short-term Investments retreated to $1.4 million in Q4 2025, from $3.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $15.3 million in Q1 2024 to a low of $1.4 million in Q4 2025.
• A 4-year average of $9.4 million and a median of $10.0 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments soared 44.83% — and 2025, when it slumped 85.84%.
• Tracing BRTX's Short-term Investments over 4 years: stood at $13.0 million in 2022, then retreated by 21.89% to $10.2 million in 2023, then increased by 0.03% to $10.2 million in 2024, then slumped by 85.84% to $1.4 million in 2025.
• The last three Short-term Investments figures came in at $1.4 million (Q4 2025), $3.9 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.